Inhibition of ion transport ATPases by HNE

BioFactors

Volumn 24, Issue 1-4, 2005, Pages 137-140

  Crifo C ^a   Capuozzo, E ^a   Siems, W ^b   Salerno, C ^a,c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Loges School of Physical Medicine   (Germany)

^c Laboratory of Clinical Biochemistry   (Italy)

Author keywords

4 hydroxynonenal; Calcium pump; Erythrocyte ghosts; Lipid peroxidation; Neutrophil membrane

Indexed keywords

4 HYDROXYNONENAL; ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE (MAGNESIUM); AMINO ACID;

ARTICLE; CELL MEMBRANE; CONCENTRATION (PARAMETERS); ENZYME INHIBITION; ENZYME MECHANISM; ERYTHROCYTE GHOST; HUMAN; INHIBITION KINETICS; ION TRANSPORT; LIPID PEROXIDATION; MOLECULAR DYNAMICS; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN FUNCTION;

EID: 28644434431     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520240116     Document Type: Article

References (34)

1. H. Esterbauer, R.J. Schaur and H. Zollner, Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes, Free Radic. Biol. Med. 11 (1991), 81-128.
2. K.S. Bandali, M.P. Belanger and C. Wittnich, Hyperoxia causes oxygen free radical-mediated membrane injury and alters myocardial function and hemodynamics in the newborn, Am. J. Physiol. Heart Circ. Physiol. 287 (2004), H553-H559.
3. T. Ogihara, K. Hirano, T. Morinobu, H.S. Kim, M. Hiroi, H. Ogihara and H. Tamai, Raised concentrations of aldehyde lipid peroxidation products in premature infants with chronic lung disease, Arch. Dis. Child Fetal Neonatal Ed. 80 (1999), F21-F25.
4. W. Siems, S. Quast, F. Carluccio, I. Wiswedel, D. Hirsch, W. Augustin, H. Hampi, M. Riehle and O. Sommerburg, Oxidative stress in chronic renal failure as a cardiovascular risk factor, Clin. Nephrol. 58(1) (2002), S12-S19.
5. K. Zarkovic, 4-Hydroxynonenal and neurodegenerative diseases, Mol. Aspects Med. 24 (2003), 293-303.
6. T. Grune, P. Michel, N. Sitte, W. Eggert, H. Albrecht-Nebe, H. Esterbauer and W. Siems, Increased levels of 4-hydroxynonenal modified proteins in plasma of children with autoimmune diseases, Free Radic. Biol. Med. 23 (1997), 357-360.
7. W. Siems, T. Grune and H. Esterbauer, 4-Hydroxynonenal formation during ischemia and reperfusion of rat small intestine, Life Sci. 57 (1995), 785-789.
8. I. Miwa, K. Adachi, S. Murase, Y. Hamada and M. Sugiura, 4-Hydroxy-2-nonenal hardly affects glycolysis, Free Radic. Biol. Med. 23 (1997), 610-615.
9. P.E. Eckl, Genotoxicity of HNE, Mol. Aspects Med. 24 (2003), 161-165.
10. K. Uchida, 4-Hydroxy-2-nonenal: A product and mediator of oxidative stress, Prog. Lipid Res. 42 (2003), 318-343.
11. G. Poli, E. Chiarpotto, F. Biasi, R. Pavia, E. Albano and M.U. Dianzani, Enzymatic impairment induced by biological aldehydes in intact rat liver cells, Res Commun Chem Pathol Pharmacol. 38 (1982), 71-76.
12. E. Paradisi, C. Panagini, M. Parola, G. Barrera and M.U. Dianzani, Effects of 4-hydroxynonenal on adenylate cyclase and 5′-nucleotidase activities in rat liver plasma membranes, Chem. Biol. Interact. 53 (1985), 209-217.
13. E. Wawra, H. Zollner, R.J. Schaur, H.M. Tillian and E. Schauenstein, The inhibitory effect of 4-hydroxy-nonenal on DNA-polymerases alpha and beta from rat liver and rapidly dividing Yoshida ascites hepatoma, Cell Biochem. Funct. 4 (1986), 31-36.
14. W. Siems, S.J. Hapner and F.J. van Kuijk, 4-Hydroxynonenal inhibits Na(+)-K(+)-ATPase, Free Radic. Biol. Med. 20 (1996), 215-223.
15. C. Salerno, W.G. Siems and C. Crifò, Succinylpurinemic autism: Increased sensitivity of defective adenylosuccinate lyase towards 4-hydroxy-2-nonenal, Biochim. Biophys. Acta 1500 (2000), 335-341.
16. L.I. Szweda, K. Uchida, L. Tsai and E.R. Stadtman, Inactivation of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal. Selective modification of an active-site lysine, J. Biol. Chem. 268 (1993), 3342-3347.
17. T. Ishii, E. Tatsuda, S. Kumazawa, T. Nakayama and K. Uchida, Molecular basis of enzyme inactivation by an endogenous electrophile 4-hydroxy-2-nonenal: Identification of modification sites in glyceraldehyde-3-phosphate dehydrogenase, Biochemistry 42 (2003), 3474-3480.
18. M. Zivkovic, K. Zarkovic, E. Skrinjar, G. Waeg, M. Poljak-Blazi, S. Borovic, R.J. Schaur and N. Zarkovic, A new method for detection of HNE-histidine conjugates in rat inflammatory cells, Croatia Chemica Acta (2005), in press.
19. 2+ permeability, Biochem. Biophys. Res. Commun. 235 (1997), 451-454.
20. B.U. Raess and F.F. Vincenzi, A semi-automated method for the determination of multiple membrane ATPase activities, J. Pharmacol. Methods 4 (1980), 273-283.
21. 2+ transport by 4-OH-2,3-trans-nonenal, Arch. Biochem. Biophys. 361 (1999), 252-256.
22. M. Parola, G. Barrera, M.C. Carasso, L. Amoroso, B. Bosia, L. Paradisi and M.U. Dianzani, Changes in the adenosinetriphosphatase activity in plasma membranes incubated in vitro in the presence of 4-hydroxy-2,3-nonenal, Boll. Soc. Ital. Biol. Sper. 58 (1982), 1199-1205.
23. R.J. Mark, M.A. Lovell, W.R. Markesbery, K. Uchida and M.P. Mattson, A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid, J. Neurochem. 68 (1997), 255-264.
24. N. Zarkovic, 4-hydroxynonenal as a bioactive marker of pathohysiological processes, Mol. Aspects Med. 24 (2003), 281-291.
25. N. Zarkovic, Z. Ilic, M. Jurin, R.J. Schaur, H. Puhl and H. Esterbauer, Stimulation of HeLa cell growth by physiological concentrations of 4-hydroxynonenal, Cell Biochem. Funct. 11 (1993), 279-286.
26. W. Siems, E. Capuozzo, A. Lucano, C. Salerno and C. Crifò, High sensitivity of plasma membrane ion transport ATPases from human neutrophils towards 4-hydroxy-2,3-trans-nonenal, Life Sci. 73 (2003), 2583-2590.
27. M. Curzio, C. Ferretti, R.J. Stephens, H. Esterbauer and M.U. Dianzani, Binding of the lipid peroxidation product 4-hydroxynonenal to human polymorphonuclear leukocytes, Cell Biochem. Funct. 12 (1994), 57-62.
28. M.A. Rossi and M.U. Dianzani, Action of 2-nonenal and 4-hydroxynonenal on phosphoinositide-specific phospholipase C in undifferentiated and DMSO-differentiated HE-60 cells, Cell Biochem. Funct. 18 (2000), 209-214.
29. S. Srivastava, B.L. Dixit, J. Cai, S. Sharma, H.E. Hurst, A. Bhatnagar and S.K. Srivastava, Metabolism of lipid peroxidation product, 4-hydroxynonenal (HNE) in rat erythrocytes: Role of aldose reductase, Free Radic. Biol. Med. 29 (2000), 642-651.
30. Di Francesco, R.W. Desnoyer, V. Covacci, F.I. Wolf, A. Romani, A. Cittadini and M. Bond, Changes in magnesium content and subcellular distribution during retinoic acid-induced differentiation of HL60 cells, Arch. Biochem. Biophys. 360 (1998), 149-157.
31. 2+ permeability, Biochem. Biophys. Res. Commun. 235 (1997), 451-454.
32. 2+ homeostatic regulation and 4-hydroxynonenal-induced aortic endothelial dysfunction, Endothelium 9 (2002), 45-53.
33. E. Donetti, M.R. Soma, L. Barberi, R. Paoletti, R. Fumagalli, P. Roma and A.L. Catalano, Dual effects of the antioxidant agents probucol and carvedilol on proliferative and fatty lesions in hypercholesterolemic rabbits, Atherosclerosis 141 (1998), 45-51.
34. K.H. Han, Y. Chen, M.K. Chang, Y.C. Han, J.-H. Park, S.R. Green, A. Boullier and O. Quehenberger, LDL activates signaling pathways leading to an increase in cytosolic free calcium and stimulation of CD11b expression in monocytes, J. Lipid Res. 44 (2003), 1332-1340.